Chronic Kidney Disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with stage 3 or higher chronic kidney disease (eGFR <60 mL/min/1.73 m2) without hemodialysis
Exclusion criteria
Exclusion criteria: 1. Patients considered by the attending physician to be inappropriate to participate in the study upon enrollment of the trial (e.g., patients undergoing treatment for malignancy, patients with active infections, etc.) 2. Patients who did not agree to participate in this clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Renal event is defined as the doubling of serum creatinine level, the initiation of renal replacement therapy, and death due to end-stage renal dysfunction. 2.To examine the cumulative incidence ratio of renal event during 5 years observation period after multidisciplinary team education. 3 To identify the beneficial or risk factors related to the occurrence of renal event. | — |
Countries
Japan
Contacts
Toda Central General Hospital Department of Nephrology